サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1420159

北米の放射性トレーサー市場、2030年までの予測 - 地域別分析：トレーサータイプ別、検査タイプ別、用途別、エンドユーザー別

North America Radioactive Tracer Market Forecast to 2030 - Regional Analysis - by Tracer Type, Test Type, Application, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 112 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.98円
北米の放射性トレーサー市場、2030年までの予測 - 地域別分析：トレーサータイプ別、検査タイプ別、用途別、エンドユーザー別
出版日: 2023年12月04日
発行: The Insight Partners
ページ情報: 英文 112 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の放射性トレーサー市場は、2022年に81億3,916万米ドルと評価され、2030年までには293億3,101万米ドルに達すると予測され、2022年から2030年までのCAGRは17.4%で成長すると予測されています。

核医学イメージング技術の使用増加が北米のヘアエクステンション市場を刺激

PETとSPECTは、臨床現場で採用されている核医学放射線モダリティの一つです。PETとSPECTは、疾患の正確な検出、局在化、特性化を提供するため、利用が増加しています。診断と治療のための電離放射線は、世界中で何百万人もの患者に利益をもたらしています。医療における放射線は、より早期の診断に役立ち、多くの場合、人間の病気に対してより侵襲性の低い治療法を提供します。高度な放射線技術は、診断、核医学、放射線治療、インターベンショナル・ラジオロジーに新たな地平を切り開きました。世界保健機関によると、年間36億件以上の診断放射線検査、3,700万件の核医学検査、750万件の放射線治療が行われています。PET/CTやSPECT/CT検査用の新しい放射性医薬品の開発とイントロダクションは、神経学や整形外科などの新しい臨床応用に使用され、さまざまな腫瘍病期分類法の精度が高まっていることが、放射性トレーサー市場の成長に寄与しています。例えば、フルピリダズF-18やアンモニアN-13のような新たに導入された心臓放射性医薬品は、心血管疾患のより正確な画像化に役立っています。このように、核イメージング技術の質と有効性を向上させるための絶え間ない技術進歩が、放射性トレーサー市場の成長を後押ししています。

北米の放射性トレーサー市場概要

北米の放射性トレーサー市場は米国、カナダ、メキシコに区分されます。2022年には、米国が北米の放射性トレーサー市場で最大のシェアを占めました。慢性疾患やウイルス性疾患に罹患する患者の増加、高度診断法の研究開発活動の活発化が、放射性トレーサー市場を推進する主な要因です。また、核画像診断技術の利用が増加していることも市場拡大を後押ししています。

北米の放射性トレーサー市場の収益と2030年までの予測

北米の放射性トレーサー市場セグメンテーション

北米の放射性トレーサー市場は、トレーサータイプ、検査タイプ、エンドユーザー、用途、国によって区分されます。トレーサータイプ別では、北米の放射性トレーサー市場はテクネチウム-99m&Tc-97m、ヨウ素131、鉄-59、ルテチウム-171、塩化ルビジウム（Rb-82）&アンモニア（N-13）、スカンジウム-46、シーボルギウム-269、ハッシウム-269に区分される、クエン酸ガリウムGa 67、前立腺特異的膜抗原（PSMA）（Ga-68）、FDDNP（F-18）＆FDOPA（F-18）、リン-32＆クロム-51、タリウム-201、F-18 FDG、F-18 FAPI、Ga-68 FAPI、F-18 PSMA、DOTATOC/DOTANOC/DOTATATE（Ga-68）、その他です。2022年には、その他セグメントが最大の市場シェアを占めました。

検査タイプ別に見ると、北米の放射性トレーサー市場はPET、SPECT、その他に区分されます。SPECTセグメントが2022年に最大の市場シェアを占めました。

エンドユーザー別では、北米の放射性トレーサー市場は病院＆クリニック、診断センター、学術＆研究機関、その他に区分されます。病院＆クリニックセグメントが2022年に最大の市場シェアを占めました。

用途別では、北米の放射性トレーサー市場は、腫瘍学、肺、神経学、心臓学、その他に区分されます。2022年には腫瘍分野が最大の市場シェアを占めました。

国別では、北米の放射性トレーサー市場は米国、カナダ、メキシコに区分されます。米国が2022年の北米の放射性トレーサー市場シェアを独占しました。

Rotem Industries Ltd、Invicro LLC、Cardinal Health Inc、Newcastle University、Novartis AG、Curium、Blue Earth Diagnostics Limited、General Electric Co、IBA Radiopharma Solutionsは、北米の放射性トレーサー市場で事業を展開する大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米の放射性トレーサー市場 - 主要産業力学

  • 主な市場促進要因
    • 慢性疾患の有病率の上昇
    • 核医学イメージング技術の使用の増加
  • 市場抑制要因
    • 放射性トレーサーの短い賞味期限
    • 核医学画像診断手順の代替品の入手可能性
  • 市場機会
    • 放射性トレーサー研究開発への新たな取り組み
  • 今後の動向
    • がん診断における放射性トレーサーの使用
  • 影響分析

第5章 放射性トレーサー市場：北米市場分析

  • 放射性トレーサー市場収益、 2022年～2030年

第6章 北米の放射性トレーサー市場 - 2030年までの収益と予測：トレーサータイプ別

  • トレーサー概要
  • 放射性トレーサー市場の収益シェア：トレーサータイプ別、2022年・2030年（%）
  • テクネチウム99mとTC-97m
  • ヨウ素131
  • 鉄59
  • ルテチウム171
  • RB82・アンモニアN-13
  • スカンジウム46
  • シーボーギウム-269
  • ハッシウム-269
  • クエン酸ガリウムGA67
  • PSMA GA68
  • FDDNP（F-18）・FDOPA（f-18）
  • リン32・クロム-51
  • タリウム-201
  • F-18 FDG
  • F-18 FAPI
  • GA 68 FAPI
  • F-18 PSMA
  • DOTATOC/DOTANOC/DOTATATE GA 68
  • その他

第7章 北米の放射性トレーサー市場 - 2030年までの収益と予測：検査タイプ別

  • 放射性トレーサー市場の収益シェア：検査タイプ別、2022年・2030年（%）
  • PET
  • SPECT
  • その他

第8章 北米の放射性トレーサー市場 - 2030年までの収益と予測：用途別

  • 放射性トレーサー市場の収益シェア：用途別、2022年・2030年（%）
  • 腫瘍
  • 肺
  • 神経学
  • 循環器
  • その他

第9章 北米の放射性トレーサー市場 - 2030年までの収益と予測：エンドユーザー別

  • 放射性トレーサー市場の収益シェア：エンドユーザー別、2022年・2030年（%）
  • 病院・診療所
  • 診断センター
  • 学術・研究機関
  • その他

第10章 北米の放射性トレーサー市場：国別分析

  • 米国
  • カナダ
  • メキシコ

第11章 放射性トレーサー市場の業界情勢

  • 有機的展開
  • 無機的展開

第12章 放射性トレーサー市場：主要企業プロファイル

  • Rotem Industries Ltd
  • Invicro LLC
  • Cardinal Health Inc
  • Newcastle University
  • Novartis AG
  • Curium
  • Blue Earth Diagnostics Limited
  • General Electric Co
  • IBA Radiopharma Solutions

第13章 付録

図表

List Of Tables

  • Table 1. North America Radioactive Tracer Market Segmentation
  • Table 2. Principal Radionuclides Used in Radioactive Tracer
  • Table 3. US Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 4. US Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 5. US Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 6. US Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 7. Canada Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 8. Canada Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 9. Canada Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 10. Canada Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 11. Mexico Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 12. Mexico Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 13. Mexico Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 14. Mexico Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 15. Organic Developments Done by Companies
  • Table 16. Inorganic Developments Done by Companies
  • Table 17. Glossary of Terms, North America Radioactive Tracer Market

List Of Figures

  • Figure 1. North America Radioactive Tracer Market Segmentation, By Country
  • Figure 2. North America Radioactive Tracer Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Radioactive Tracer Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. North America Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
  • Figure 6. Technetium 99m and TC-97m: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Iodine 131: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Iron 59: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Lutetium- 171: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. RB82 and ammonia N-13: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Scandium 46: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Seaborgium-269: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Hassium -269: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Gallium Citrate GA 67: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. PSMA GA68: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. FDDNP (F-18) and FDOPA (f-18): North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Phosphorus 32 and Chromium -51: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Thallium-201: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. F-18 FDG: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. F-18 FAPI: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. GA 68 FAPI: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. F-18 PSMA: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. DOTATOC/DOTANOC/DOTATATE Ga 68: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. North America Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 26. PET: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. SPECT: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. North America Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 30. Oncology: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Pulmonary: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Neurology: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. Cardiology: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. Others: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. North America Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 36. Hospitals and Clinics: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Diagnostic Centers: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 38. Academic and Research Institutes: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 39. Others: North America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 40. North America Radioactive Tracer Market, by Country 2022 ($Mn)
  • Figure 41. North America Radioactive Tracer Market, By Key Countries, 2022 And 2030 (%)
  • Figure 42. US Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 43. Canada Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 44. Mexico Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
目次
Product Code: BMIRE00029121

The North America radioactive tracer market was valued at US$ 8,139.16 million in 2022 and is expected to reach US$ 29,331.01 million by 2030; it is estimated to grow at a CAGR of 17.4% from 2022 to 2030.

Increasing Use of Nuclear Imaging Techniques fuel the North America Hair Extension Market

PET and SPECT are among the nuclear medicine radiology modalities employed in clinical settings. Their use is increasing as they offer accurate detection, localization, and characterization of diseases. Ionizing radiation for diagnosis and treatment benefits millions of patients globally. Radiation in medicine helps earlier diagnosis and often offers less invasive treatments for human diseases. Advanced radiation technology has opened new horizons in diagnostic and nuclear medicine, radiotherapy, and interventional radiology. According to World Health Organization, over 3,600 million diagnostic radiology examinations are performed, 37 million nuclear medicine procedures are carried out, and 7.5 million radiotherapy treatments are given annually. The development and introduction of new radiopharmaceuticals for PET/CT and SPECT/CT procedures, which are used in novel clinical applications such as neurology and orthopedics, and the growing accuracy of different tumor staging methods contribute to the growth of the radioactive tracer market. For instance, newly introduced cardiac radiopharmaceuticals such as flurpiridaz F-18 and ammonia N-13 help in more precise imaging of cardiovascular conditions. Thus, constant technological advancements for improving the quality and efficacy of nuclear imaging techniques favor the growth of the radioactive tracer market.

North America Radioactive Tracer Market Overview

The North America radioactive tracer market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest share of the North America radioactive tracer market. Rising number of patients suffering from chronic conditions and viral diseases, increasing activities in research and development in advanced diagnosis method are the key factors propelling the market for radioactive tracer. Also, the increasing use of nuclear imaging techniques are favoring market expansion.

North America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Million)

North America Radioactive Tracer Market Segmentation

The North America radioactive tracer market is segmented based on tracer type, test type, end user, application, and country. Based on tracer type, the North America radioactive tracer market is segmented into technetium-99m & Tc-97m, iodine-131, iron-59, lutetium-171, rubidium (Rb-82) chloride & ammonia (N-13), scandium-46, seaborgium-269, hassium-269, Gallium citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), phosphorus-32 & chromium-51, thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and others. The others segment held the largest market share in 2022.

Based on test type, the North America radioactive tracer market is segmented into PET, SPECT, and others. The SPECT segment held the largest market share in 2022.

Based on end user, the North America radioactive tracer market is segmented into hospitals & clinics, diagnostic centers, academic & research institutes, and others. The hospitals & clinics segment held the largest market share in 2022.

Based on application, the North America radioactive tracer market is segmented into oncology, pulmonary, neurology, cardiology, and others. The oncology segment held the largest market share in 2022.

Based on country, the North America radioactive tracer market is segmented into the US, Canada, and Mexico. The US dominated the North America radioactive tracer market share in 2022.

Rotem Industries Ltd, Invicro LLC, Cardinal Health Inc, Newcastle University, Novartis AG, Curium, Blue Earth Diagnostics Limited, General Electric Co, and IBA Radiopharma Solutions are some of the leading players operating in the North America radioactive tracer market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America radioactive tracer market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America radioactive tracer market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America radioactive tracer market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Radioactive Tracer Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Rising Prevalence of Chronic Diseases
    • 4.1.2 Increasing Use of Nuclear Imaging Techniques
  • 4.2 Market Restraints
    • 4.2.1 Short Shelf-Life of Radioactive Tracer
    • 4.2.2 Availability of Substitutes to Nuclear Diagnostic Imaging Procedures
  • 4.3 Market Opportunities
    • 4.3.1 New Initiatives for Radioactive Tracer R&D
  • 4.4 Future Trends
    • 4.4.1 Use of Radioactive Tracer in Cancer Diagnosis
  • 4.5 Impact Analysis:

5. Radioactive Tracer Market - North America Market Analysis

  • 5.1 Radioactive Tracer Market Revenue (US$ Mn), 2022 - 2030

6. North America Radioactive Tracer Market - Revenue and Forecast to 2030 - by Tracer Types

  • 6.1 Overview
  • 6.2 Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
  • 6.3 Technetium 99m and TC-97m
    • 6.3.1 Overview
    • 6.3.2 Technetium 99m and TC-97m: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Iodine 131
    • 6.4.1 Overview
    • 6.4.2 Iodine 131: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Iron 59
    • 6.5.1 Overview
    • 6.5.2 Iron 59: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Lutetium- 171
    • 6.6.1 Overview
    • 6.6.2 Lutetium- 171: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.7 RB82 and ammonia N-13
    • 6.7.1 Overview
    • 6.7.2 RB82 and ammonia N-13: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Scandium 46
    • 6.8.1 Overview
    • 6.8.2 Scandium 46: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.9 Seaborgium-269
    • 6.9.1 Overview
    • 6.9.2 Seaborgium-269: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.10 Hassium -269
    • 6.10.1 Overview
    • 6.10.2 Hassium -269: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.11 Gallium Citrate GA 67
    • 6.11.1 Overview
    • 6.11.2 Gallium Citrate GA 67: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.12 PSMA GA68
    • 6.12.1 Overview
    • 6.12.2 PSMA GA68: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.13 FDDNP (F-18) and FDOPA (f-18)
    • 6.13.1 Overview
    • 6.13.2 FDDNP (F-18) and FDOPA (f-18): Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.14 Phosphorus 32 and Chromium -51
    • 6.14.1 Overview
    • 6.14.2 Phosphorus 32 and Chromium -51: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.15 Thallium-201
    • 6.15.1 Overview
    • 6.15.2 Thallium-201: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.16 F-18 FDG
    • 6.16.1 Overview
    • 6.16.2 F-18 FDG: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.17 F-18 FAPI
    • 6.17.1 Overview
    • 6.17.2 F-18 FAPI: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.18 GA 68 FAPI
    • 6.18.1 Overview
    • 6.18.2 GA 68 FAPI: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.19 F-18 PSMA
    • 6.19.1 Overview
    • 6.19.2 F-18 PSMA: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.20 DOTATOC/DOTANOC/DOTATATE Ga 68
    • 6.20.1 Overview
    • 6.20.2 DOTATOC/DOTANOC/DOTATATE Ga 68: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.21 Others
    • 6.21.1 Overview
    • 6.21.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Radioactive Tracer Market - Revenue and Forecast to 2030 - by Test Type

  • 7.1 Overview
  • 7.2 Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 7.3 PET
    • 7.3.1 Overview
    • 7.3.2 PET: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 SPECT
    • 7.4.1 Overview
    • 7.4.2 SPECT: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Radioactive Tracer Market - Revenue and Forecast to 2030 - by Application.

  • 8.1 Overview
  • 8.2 Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Oncology
    • 8.3.1 Overview
    • 8.3.2 Oncology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Pulmonary
    • 8.4.1 Overview
    • 8.4.2 Pulmonary: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Neurology
    • 8.5.1 Overview
    • 8.5.2 Neurology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Cardiology
    • 8.6.1 Overview
    • 8.6.2 Cardiology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Radioactive Tracer Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Centers
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Centers: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Radioactive Tracer Market - Country Analysis

  • 10.1 North America Radioactive Tracer Market, Revenue and Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 North America Radioactive Tracer Market, by Country
      • 10.1.2.1 US
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 US Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.1.3 US Radioactive Tracer Market, by Tracer Types
        • 10.1.2.1.4 US Radioactive Tracer Market, by Test Type
        • 10.1.2.1.5 US Radioactive Tracer Market, by Application
        • 10.1.2.1.6 US Radioactive Tracer Market, by End-User
      • 10.1.2.2 Canada
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Canada Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.3 Canada Radioactive Tracer Market, by Tracer Types
        • 10.1.2.2.4 Canada Radioactive Tracer Market, by Test Type
        • 10.1.2.2.5 Canada Radioactive Tracer Market, by Application
        • 10.1.2.2.6 Canada Radioactive Tracer Market, by End-User
      • 10.1.2.3 Mexico
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 Mexico Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.3.3 Mexico Radioactive Tracer Market, by Tracer Types
        • 10.1.2.3.4 Mexico Radioactive Tracer Market, by Test Type
        • 10.1.2.3.5 Mexico Radioactive Tracer Market, by Application
        • 10.1.2.3.6 Mexico Radioactive Tracer Market, by End-User

11. Radioactive Tracer Market Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Developments
    • 11.2.1 Overview
  • 11.3 Inorganic Developments
    • 11.3.1 Overview

12. Radioactive Tracer Market, Key Company Profiles

  • 12.1 Rotem Industries Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Invicro LLC
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Cardinal Health Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Newcastle University
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Novartis AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Curium
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Blue Earth Diagnostics Limited
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 General Electric Co
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 IBA Radiopharma Solutions
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms